Literature DB >> 9023806

The use and cost of hospital services by London AIDS patients with different AIDS defining conditions.

E J Beck1, E J Kupek, J Wadsworth, D L Miller, A J Pinching, J R Harris.   

Abstract

BACKGROUND: Contracting for HIV service provision is now an established part of the National Health Service commissioning process. AIDS is a heterogeneous condition, comprising various opportunistic illnesses which require different services and which have different resource implications. This study describes the use of hospital services and associated costs for the management of different AIDS defining conditions.
METHOD: A retrospective case-notes analysis was performed, of 335 AIDS patients treated at St Mary's Hospital, London, between 1 January 1983 and 30 September 1989, as well as a costing exercise of 37 clinical departments to calculate HIV-related costs.
RESULTS: Mean age at time of AIDS diagnosis for these predominantly homosexual men was 38 years. Use of services varied, as did associated costs-from 8163 pounds per patient-year for patients with Constitutional Disease to 42,124 pounds for those with Cytomegalovirus Disease Most diagnostic categories showed a shift over the study period from an in-patient- to an out-patient-based service. Patients diagnosed after 1987 had overall lower costs per patient-year compared with those diagnosed before 1987: whereas out-patient costs for most groups had increased, in-patient expenditure decreased. For most categories, in-patient care costs and out-patient drugs prescribed provided the greatest proportion of total costs. Average costs per in-patient day ranged from 334 pounds to 433 pounds, and average costs per out-patient visit ranged from 99 pounds to 411 pounds for different AIDS defining conditions.
CONCLUSIONS: Different opportunistic illnesses of symptomatic HIV disease have different treatment and resource implications. Casemix will need to be taken into consideration when contracting for HIV services, including extra-contractual referrals.

Entities:  

Mesh:

Year:  1996        PMID: 9023806     DOI: 10.1093/oxfordjournals.pubmed.a024545

Source DB:  PubMed          Journal:  J Public Health Med        ISSN: 0957-4832


  4 in total

Review 1.  Health economics in HIV disease. A review of the European literature.

Authors:  M Youle; P Trueman; K Simpson
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

2.  A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspective.

Authors:  L Lacey; M Youle; P Trueman; S Staszewski; M Schrappe; M Behrens
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 3.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

4.  The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs.

Authors:  E J Beck; K Tolley; A Power; S Mandalia; P Rutter; J Izumi; J Beecham; A Gray; D Barlow; P Easterbrook; M Fisher; J Innes; G Kinghorn; B Mandel; A Pozniak; A Tang; D Tomlinson; I Williams
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.